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n heart muscle, the process of excitation-contraction (EC) coupling is of vital importance because it links the electrical excitation to the mechanical activity of cardiac muscle cells. Would it be reasonable to assume that this crucial process underlies some physiological regulation or that it is affected by certain pathological cardiac conditions? If this question had been presented to an expert in the field only a few years ago, the answer would almost inevitably have been "No!" Why expect such a dogmatic response? Cardiac EC coupling is known to be initiated by Ca 2+ influx into cardiac myocytes via voltage-dependent L-type Ca 2+ channels (i.e., dihydropyridine receptors, DHPRs) that are activated during each action potential (see Fig. 1 ). This initial signal acts only as a trigger for subsequent Ca 2+ -induced Ca 2+ release (CICR) from intracellular Ca 2+ stores in the sarcoplasmic reticulum (SR). This secondary Ca 2+ release occurs via large homotetrameric Ca 2+ -release channels (i.e., the ryanodine receptors, RyRs), located in the membrane of the SR. In most mammalian species, CICR amplifies the initial trigger signal severalfold. Because this amplification system functions reliably during billions of heartbeats over several decades (in human hearts), the chances for CICR to fail must be exceedingly small. In fact, should it fail, the heart would immediately stop beating. Therefore, it seems unlikely that nature would tinker with such a vital system and dare to regulate it. The purpose of this review is to outline how and why the answer to the question posed above has fundamentally changed during the last few years.
The paradox of cardiac Ca 2+ signaling
CICR is known to be an amplification system with a remarkable peculiarity. The trigger signal for the SR Ca 2+ release, an elevation of the cytosolic Ca 2+ concentration ([Ca   2+ ] i ), is identical to the output signal of this amplifier, again an elevation of [Ca 2+ ] i . This feature is readily expected to result in a high degree of positive feedback; thus the system should behave in an all-or-none fashion. Allor-none behavior of the CICR would guarantee a broad margin of safety and thus could be responsible for the high degree of reliability. This view indeed found robust experimental support after the observation of spontaneous contractile waves in isolated cardiac myocytes. These mechanical waves were shown to correspond to waves of elevated Ca 2+ traveling along the cell (15) . These Ca 2+ signals are reaction-diffusion waves driven by the CICR mechanism operating at a very high gain, consistent with the suspected all-or-none behavior of this amplification system. Therefore, the picture of a safe and reliable cardiac EC coupling system operating under a high positive feedback regime with all-or-none CICR emerged, and almost everyone was satisfied with this view.
However, a few years ago several disturbing and incompatible experimental observations were reported that did not appear to fit into this picture. First of all, it was clearly shown by several research laboratories that Ca 2+ release from the SR was not necessarily all-or-none. In contrast, it was found that small or abbreviated L- Besides presenting a possible explanation for the cardiac Ca 2+ signaling paradox outlined above, the existence of functionally discrete and independent Ca 2+ signaling units would, in principle, also allow for a partial disruption of the EC coupling system without catastrophic consequences for cardiac pumping. A partial failure of EC coupling could thus lead to a degradation of the cardiac mechanical performance that is, at least transiently, proportional to the degree of impaired EC coupling.
Ca

2+ signaling is affected in various cardiac disease models
Cardiac force may decline because of a modification of the Ca 2+ sensitivity of the myofilaments, a deterioration of the Ca 2+ signals, or both. Disease-related changes of Ca 2+ signaling in heart muscle have been investigated in several laboratories. Numerous studies have been conducted in a variety of preparations and animal disease models and also in human tissue and isolated myocytes (3). In general, the literature is highly controversial, possibly as a result of peculiarities in the disease models used. In addition, it is frequently not yet clear whether the observed changes of cardiac Ca 2+ signaling are pathogenic to a particular disease or an adaptive consequence of the deteriorated cardiac function. Nevertheless, the following general picture has emerged. During many cardiac conditions, including hypertrophy and failure, several Ca 2+ signaling pathways are affected. In the majority of studies on failing hearts, resting [Ca 2+ ] i was found to be slightly elevated whereas the Ca 2+ transients were reduced in amplitude and exhibited a slowed relaxation. In particular, the function of the SR Ca 2+ pump and the Na + /Ca 2+ exchanger was found to be altered to varying degrees, with the SR Ca 2+ pump frequently exhibiting a diminished expression. In some studies, but not all, the observed changes in the expression of the protein or mRNA were paralleled by alterations of transport function. In other studies, changes of Ca 2+ signaling appeared to result from a functional modification of a particular transporter and not from a change in the amount of expressed protein. 
Impaired EC coupling may be relevant for cardiac failure
Safety and reliability were considered to be the most salient features of EC coupling, and there appeared to be little room for regulation or modulation of this vital signaling step, as outlined above. Thus cardiac dysfunction was believed to arise primarily from disturbances taking place either before or after EC coupling itself (for example, a reduction of the Ca 2+ current or an impaired SR Ca 2+ buffering causing less release and slowed Ca 2+ reuptake). Because this view prevailed until recently, it came as a surprise when experiments performed in cardiac myocytes isolated from spontaneously hypertensive rats with heart failure suggested that EC coupling itself may indeed be affected. When the probability of L-type Ca 2+ channel openings to trigger SR Ca 2+ release via RyRs was examined, it was found that hypertrophied as well as failing hearts showed a decreased EC coupling efficiency (2). However, both the L-type Ca 2+ current and the SR Ca 2+ -release mechanism itself appeared to be unaffected by the disease and were normal. These observations were interpreted to indicate that the problem may reside in the link between the two Ca 2+ signaling proteins, the DHPRs and the RyRs. This view was supported by the observation that increasing the Ca 2+ influx via the L-type Ca 2+ current by β-adrenergic stimulation restored the coupling process to normal in hypertrophied cells (but not in cells isolated from failing hearts). β-Adrenergic stimulation can prolong the open time of the L-type Ca 2+ channels and therefore increase the amount of Ca 2+ entering during a given single channel opening. How could β-adrenergic stimulation thereby restore the failing Ca 2+ signaling link? As an attractive hypothesis, it has been proposed that the impaired EC coupling may result from a disarrangement in the microarchitecture of the abutting DHPRs and RyRs. In other words, the juxtaposition of DHPRs and RyRs may have become disrupted or the volume into which Ca 2+ is distributing within the dyadic cleft may have increased (2) . Although this is an intriguing possibility, to date no direct evidence for this hypothesis is available and other mechanisms are also conceivable. For example, the Ca 2+ sensitivity of the RyRs may have decreased as a direct or indirect consequence of the disease. β-Adrenergic stimulation could then restore normal Ca 2+ sensitivity, possibly via phosphorylation of the RyRs. In addition, increased influx of Ca 2+ during L-type Ca 2+ current would raise the SR Ca 2+ load and produce a more maintained augmentation of the Ca 2+ signal. In another study performed in rats, arterial hypertension was induced by introducing a constriction of the abdominal aorta ("banding"; Ref. In summary, cardiac diseases appear to exist that can seriously interfere with the efficacy and reliability of the EC coupling process. Improving the performance of this crucial process may offer a new avenue to pharmacological treatment of cardiac hypertrophy and failure.
Are there other safety mechanisms to ensure reliable EC coupling?
It is also important to note that disturbances of EC coupling may have a tendency to be self-limiting or even transient, because, as the Ca 2+ release from the SR is reduced, the SR Ca 2+ load increases gradually and this would compensate for the reduced trigger efficiency. From the beneficial effect of β-adrenergic stimulation it can be concluded that compensatory mechanisms during cardiac hypertrophy may be able to maintain sufficient EC coupling despite some problems in the EC coupling machinery. In addition to the compensatory increase of L-type Ca 2+ flux, other safety mechanisms may work in parallel. Some of these mechanisms could be functioning continuously, whereas others might only become activated when the heart starts to fail. It is conceivable that such parallel mechanisms may boost EC coupling and provide additional safety that guarantees reliable coupling. Indeed, during the last few years several mechanisms have been proposed to work in parallel with the L-type Ca 2+ current. However, the observations underlying these suggestions were made under highly artificial experimental conditions. Thus their relevance during normal Ca 2+ signaling is not known at present. Although such redundant mechanisms may not be important normally, they may become essential in pathological conditions. As a starting point, it seems appropriate to consider such auxiliary mechanisms as possible safety nets.
Most proposed supplementary coupling schemes imply a pathway for transsarcolemmal Ca 2+ entry different from L-type Ca 2+ current that may be activated during the action potential. With a few exceptions, the existence of these pathways is fairly well established and they are known to be able to carry Ca 2+ into cardiac myocytes. However, the Ca 2+ flux normally mediated by each of these mechanisms was not generally thought to be sufficient to account for significant Ca 2+ release from the SR. 
Na
T-type Ca
2+ current and slip-mode Ca 2+ conductance of Na + channels
Many mammalian cardiac myocytes contain Ttype Ca 2+ channels, in addition to the L type. Compared to the latter, T-type channels activate and inactivate at more negative membrane potentials. Therefore, their contribution may also have been overlooked in experiments in which cells were predepolarized to inactivate I Na . In a recent study that was designed to investigate a possible role of the T-type Ca 2+ current during EC coupling, a small contribution of these Ca 2+ channels was suspected (12) , but the coupling efficacy appeared to be smaller than for the L-type channels.
Earlier, cardiac TTX-sensitive Na + channels were suspected to carry Ca 2+ but only noticeably when the extracellular Na + concentration was very low. Surprisingly, a recent report suggested that after β-adrenergic stimulation, the Na + selectivity of the TTX-sensitive Na + channels dramatically diminishes, allowing significant Ca 2+ influx during I Na (11) . In fact, the permeability ratio for Na + to Ca 2+ was determined to be 1:1.25 after β-adrenergic stimulation, and the Ca 2+ influx was found to be sufficient to trigger SR Ca 2+ release on its own. Therefore, I Na may kick in as an auxiliary pathway for Ca 2+ entry into cardiac myocytes under conditions of β-adrenergic stimulation. -release channel is the IP 3 receptor (IP 3 R) with many structural and functional similarities to the RyRs. Because IP 3 Rs were also detected in cardiac muscle, several studies investigated the role of IP 3 in cardiac EC coupling. The present view is that, in cardiac muscle, IP 3 only generates small Ca 2+ release signals that are also too slow to participate in rapid EC coupling events. However, this signaling system could play a modulatory or compensatory role during some cardiac diseases.
Ca
EC coupling may be clinically relevant
The discovery of elementary events for Ca 2+ signaling was helpful for solving a paradox in cardiac Ca 2+ signaling. Together with several potential auxiliary pathways for cardiac Ca 2+ signaling, Ca 2+ sparks also allow for a partial failure of EC coupling without catastrophic consequences. Sorting out the precise contribution of each EC coupling pathway in normal and pathological conditions will be difficult and will require much more work because of the complexity of cardiac Ca 2+ signaling. Therefore, the answer to the question posed in the title of the present review is not straightforward. The heart seems to be able to cope with a reduced efficiency of Ca 2+ spark generation, but at present we do not yet know to what extent other Ca 2+ signaling pathways can compensate for a partial failure of the L-type Ca 2+ current as the main trigger. However, as we untangle this complex system in the future, we may be able to conceptualize completely new pharmacological strategies. It is also pleasing that this notable opportunity directly illustrates the potential and benefit of basic research. Even if the "value" of this research is not immediate in terms of financial profit, it is impossible to predict, by both scientists and politicians, whether an apparently small piece of the puzzle may become pivotal for the big picture at some time in the future. Taken together, these results suggest that EC coupling may be more important than previously thought for both cardiac physiology and pathophysiology. 
